glp 1 agonists and depression GLP-1 medications used to treat diabetes obesity may also help alleviate symptoms of anxiety and A new target trial emulation

PubMed pubmed.ncbi.nlm.nih.gov [31] Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist, a step forward in the treatment of diabetes and obesity

Together, these rat studies suggest that the weight-lowering potential of GLP-1MK-801 is not associated with exacerbated nausea

10.1056/NEJMoa2401755 68 ShabilM.KhatibM

Dec 21 [cited 2024 Feb 28]

This review by Oliver Philps provides an overview of GLP-1 agonists and where they fit in the treatment of diabetes, how the peptide drugs evolved over time to todays weight loss medications, and what to expect next...

After 5 weeks of treatment with once-daily subcutaneous administration of liraglutide 1.8 mg and 3.0 mg, estimated reductions in body weight were 2.1 kg and 2.5 kg, respectively, vs